Showing results (611-620 of 1,126) with videos related to

Sort By:
Pageof 113
Cancer Genetics|December 17, 2018
Clinical impact of MYC abnormalities in plasma cell myelomaRolando García, Weina Chen, Prasad Koduru
Cancer Genetics|December 17, 2018
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 casesFrancesca Magnoli, Barbara Bernasconi, Lisa Vivian, et al.
Cancer Genetics|December 17, 2018
Identification of gene-specific DNA methylation signature for Colorectal CancerKaixue Li, Li Zeng, Hong Wei, et al.
Cancer Genetics|December 17, 2018
An expression quantitative trait locus variant for LKB1 gene predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancerHyewon Seo, Deuk Kju Jung, Hyo-Gyoung Kang, et al.
Cancer Genetics|December 17, 2018
Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and SoutheastPaula Silva Felicio, Barbara Alemar, Aline Silva Coelho, et al.
Cancer Genetics|November 19, 2019
Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigensSharad Khurana, Megan E Melody, Rhett P Ketterling, et al.
Cancer Genetics|November 15, 2019
Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCCQian Wang, Han Liu, Zihao Liu, et al.
Cancer Genetics|January 19, 2023
Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53Cynthia A Schandl, Sandra Mazzoni, Iya Znoyko, et al.
Cancer Genetics|July 27, 2021
Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancerSun Young Kim, Kwoneel Kim, Su Han Cho, et al.
Cancer Genetics|October 23, 2018
Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working groupXinjie Xu, Christine Bryke, Madina Sukhanova, et al.
Pageof 113